Nicotinic acetylcholine receptor antagonistic property of the selective dopamine uptake inhibitor, GBR-12909 in rat hippocampal slices

Abstract Previously we found that inhibitors of noradrenaline (NA) and/or 5-HT reuptake are able to inhibit neuronal nicotinic acetylcholine receptors (nAChRs) in the CNS most probably by a channel blocker-type mechanism. The aim of our study was to clarify whether selective dopamine uptake inhibito...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuroscience 2007-03, Vol.145 (1), p.344-349
Hauptverfasser: Szasz, B.K, Vizi, E.S, Kiss, J.P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 349
container_issue 1
container_start_page 344
container_title Neuroscience
container_volume 145
creator Szasz, B.K
Vizi, E.S
Kiss, J.P
description Abstract Previously we found that inhibitors of noradrenaline (NA) and/or 5-HT reuptake are able to inhibit neuronal nicotinic acetylcholine receptors (nAChRs) in the CNS most probably by a channel blocker-type mechanism. The aim of our study was to clarify whether selective dopamine uptake inhibitors also possess this property, therefore we investigated the effect of GBR-12909 on the nicotine-evoked release of [3 H]NA from rat hippocampal slices. GBR-12909, similar to selective NA and 5-HT uptake blockers, inhibited the nicotine-evoked release with an IC50 of 2.32 μM. The ability of monoamine uptake blockers to inhibit nicotine-evoked [3 H]NA release (IC50 ) and NA reuptake ( Ki ) showed no correlation, indicating that the NA uptake system is not involved in the inhibition of the response to nicotine. Previously we have shown in whole cell patch clamp experiments, that GBR-12909, depending on the stimulation pattern, inhibits Na+ -currents with an IC50 in the 6–35 μM concentration range [Mike A, Karoly R, Vizi ES, Kiss JP (2003) Inhibitory effect of the DA uptake blocker GBR-12909 on sodium channels of hippocampal neurons. Neuroreport 14:1945–1949]. To study whether the inhibition of Na+ -channels is involved in the action of GBR-12909 on the nicotine-evoked [3 H]NA release, we compared the effect of GBR-12909 and the Na+ -channel blocker tetrodotoxin (TTX) on the electrical stimulation- and nicotine-evoked response. TTX prevented the release of [3 H]NA induced by both types of stimulation, whereas GBR-12909 inhibited only the nicotine-induced response, indicating that under our experimental conditions the target of GBR-12909 is not the Na+ -channel. These data indicate that the selective DA uptake inhibitor GBR-12909 is able to inhibit nAChRs, that is, the nAChR antagonistic property of monoamine uptake inhibitors is independent of their selectivity. The fact that monoamine uptake inhibitors with different chemical structure and selectivity are able to inhibit nAChRs may reveal some common properties of nicotinic receptors and monoamine uptake carriers.
doi_str_mv 10.1016/j.neuroscience.2006.11.032
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_19693384</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S030645220601640X</els_id><sourcerecordid>19693384</sourcerecordid><originalsourceid>FETCH-LOGICAL-c494t-4e0ae7de1fa5cb851b6f8a3d095c331aa90753f7ba449ca15c2eb3d7d903c32a3</originalsourceid><addsrcrecordid>eNqNkt2K1TAUhYsoznH0FSQIemVr0qQ_8ULQUUdhUPAHvAu76a4nZ9KmJunAeQGf25RTGPHK3ATCt9fOXmtn2RNGC0ZZ_eJQTLh4F7TBSWNRUloXjBWUl3eyHWsbnjeVEHezHeW0zkVVlmfZgxAONJ1K8PvZGWtK2lSt2GW_PxntopmMJqAxHq3eO2smJB41ztF5AlOEn24yISZm9m5GH4_EDSTukQS0qKO5QdK7Gca1cJkjXCMx0950Jgk8J5dvvuSslFSmR-Ihkr2ZZ6dhnMGSYI3G8DC7N4AN-Gi7z7Pv7999u_iQX32-_Hjx-irXQoqYC6SATY9sgEp3bcW6emiB91RWmnMGINNYfGg6EEJqYJUuseN900vKNS-Bn2fPTrppkF8LhqhGEzRaCxO6JSgma8l5KxL48gTqZHTwOKjZmxH8UTGq1hTUQf2dglpTUIyplEIqfrx1WboR-9vSzfYEPN0ACBrs4GHSJtxybVWJUsrEvT1xmDy5MejV1q43KZ-oemf-7z-v_pHRdo0c7DUeMRzc4qfkumIqlIqqr-verGtD6yQs6A_-B-S4xHg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19693384</pqid></control><display><type>article</type><title>Nicotinic acetylcholine receptor antagonistic property of the selective dopamine uptake inhibitor, GBR-12909 in rat hippocampal slices</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Szasz, B.K ; Vizi, E.S ; Kiss, J.P</creator><creatorcontrib>Szasz, B.K ; Vizi, E.S ; Kiss, J.P</creatorcontrib><description>Abstract Previously we found that inhibitors of noradrenaline (NA) and/or 5-HT reuptake are able to inhibit neuronal nicotinic acetylcholine receptors (nAChRs) in the CNS most probably by a channel blocker-type mechanism. The aim of our study was to clarify whether selective dopamine uptake inhibitors also possess this property, therefore we investigated the effect of GBR-12909 on the nicotine-evoked release of [3 H]NA from rat hippocampal slices. GBR-12909, similar to selective NA and 5-HT uptake blockers, inhibited the nicotine-evoked release with an IC50 of 2.32 μM. The ability of monoamine uptake blockers to inhibit nicotine-evoked [3 H]NA release (IC50 ) and NA reuptake ( Ki ) showed no correlation, indicating that the NA uptake system is not involved in the inhibition of the response to nicotine. Previously we have shown in whole cell patch clamp experiments, that GBR-12909, depending on the stimulation pattern, inhibits Na+ -currents with an IC50 in the 6–35 μM concentration range [Mike A, Karoly R, Vizi ES, Kiss JP (2003) Inhibitory effect of the DA uptake blocker GBR-12909 on sodium channels of hippocampal neurons. Neuroreport 14:1945–1949]. To study whether the inhibition of Na+ -channels is involved in the action of GBR-12909 on the nicotine-evoked [3 H]NA release, we compared the effect of GBR-12909 and the Na+ -channel blocker tetrodotoxin (TTX) on the electrical stimulation- and nicotine-evoked response. TTX prevented the release of [3 H]NA induced by both types of stimulation, whereas GBR-12909 inhibited only the nicotine-induced response, indicating that under our experimental conditions the target of GBR-12909 is not the Na+ -channel. These data indicate that the selective DA uptake inhibitor GBR-12909 is able to inhibit nAChRs, that is, the nAChR antagonistic property of monoamine uptake inhibitors is independent of their selectivity. The fact that monoamine uptake inhibitors with different chemical structure and selectivity are able to inhibit nAChRs may reveal some common properties of nicotinic receptors and monoamine uptake carriers.</description><identifier>ISSN: 0306-4522</identifier><identifier>EISSN: 1873-7544</identifier><identifier>DOI: 10.1016/j.neuroscience.2006.11.032</identifier><identifier>PMID: 17207584</identifier><identifier>CODEN: NRSCDN</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Anesthetics, Local - pharmacology ; Animals ; Biological and medical sciences ; Dopamine Uptake Inhibitors - pharmacology ; Dose-Response Relationship, Drug ; Fundamental and applied biological sciences. Psychology ; GBR-12909 ; Hippocampus - drug effects ; In Vitro Techniques ; Male ; monoamine uptake systems ; Neurology ; Nicotine - metabolism ; Nicotine - pharmacology ; nicotinic acetylcholine receptors ; Nicotinic Antagonists - pharmacology ; Piperazines - pharmacology ; Rats ; Rats, Wistar ; selective dopamine uptake inhibitors ; Tetrodotoxin - pharmacology ; Tritium - metabolism ; Vertebrates: nervous system and sense organs</subject><ispartof>Neuroscience, 2007-03, Vol.145 (1), p.344-349</ispartof><rights>IBRO</rights><rights>2006 IBRO</rights><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c494t-4e0ae7de1fa5cb851b6f8a3d095c331aa90753f7ba449ca15c2eb3d7d903c32a3</citedby><cites>FETCH-LOGICAL-c494t-4e0ae7de1fa5cb851b6f8a3d095c331aa90753f7ba449ca15c2eb3d7d903c32a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.neuroscience.2006.11.032$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18554299$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17207584$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Szasz, B.K</creatorcontrib><creatorcontrib>Vizi, E.S</creatorcontrib><creatorcontrib>Kiss, J.P</creatorcontrib><title>Nicotinic acetylcholine receptor antagonistic property of the selective dopamine uptake inhibitor, GBR-12909 in rat hippocampal slices</title><title>Neuroscience</title><addtitle>Neuroscience</addtitle><description>Abstract Previously we found that inhibitors of noradrenaline (NA) and/or 5-HT reuptake are able to inhibit neuronal nicotinic acetylcholine receptors (nAChRs) in the CNS most probably by a channel blocker-type mechanism. The aim of our study was to clarify whether selective dopamine uptake inhibitors also possess this property, therefore we investigated the effect of GBR-12909 on the nicotine-evoked release of [3 H]NA from rat hippocampal slices. GBR-12909, similar to selective NA and 5-HT uptake blockers, inhibited the nicotine-evoked release with an IC50 of 2.32 μM. The ability of monoamine uptake blockers to inhibit nicotine-evoked [3 H]NA release (IC50 ) and NA reuptake ( Ki ) showed no correlation, indicating that the NA uptake system is not involved in the inhibition of the response to nicotine. Previously we have shown in whole cell patch clamp experiments, that GBR-12909, depending on the stimulation pattern, inhibits Na+ -currents with an IC50 in the 6–35 μM concentration range [Mike A, Karoly R, Vizi ES, Kiss JP (2003) Inhibitory effect of the DA uptake blocker GBR-12909 on sodium channels of hippocampal neurons. Neuroreport 14:1945–1949]. To study whether the inhibition of Na+ -channels is involved in the action of GBR-12909 on the nicotine-evoked [3 H]NA release, we compared the effect of GBR-12909 and the Na+ -channel blocker tetrodotoxin (TTX) on the electrical stimulation- and nicotine-evoked response. TTX prevented the release of [3 H]NA induced by both types of stimulation, whereas GBR-12909 inhibited only the nicotine-induced response, indicating that under our experimental conditions the target of GBR-12909 is not the Na+ -channel. These data indicate that the selective DA uptake inhibitor GBR-12909 is able to inhibit nAChRs, that is, the nAChR antagonistic property of monoamine uptake inhibitors is independent of their selectivity. The fact that monoamine uptake inhibitors with different chemical structure and selectivity are able to inhibit nAChRs may reveal some common properties of nicotinic receptors and monoamine uptake carriers.</description><subject>Anesthetics, Local - pharmacology</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Dopamine Uptake Inhibitors - pharmacology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>GBR-12909</subject><subject>Hippocampus - drug effects</subject><subject>In Vitro Techniques</subject><subject>Male</subject><subject>monoamine uptake systems</subject><subject>Neurology</subject><subject>Nicotine - metabolism</subject><subject>Nicotine - pharmacology</subject><subject>nicotinic acetylcholine receptors</subject><subject>Nicotinic Antagonists - pharmacology</subject><subject>Piperazines - pharmacology</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>selective dopamine uptake inhibitors</subject><subject>Tetrodotoxin - pharmacology</subject><subject>Tritium - metabolism</subject><subject>Vertebrates: nervous system and sense organs</subject><issn>0306-4522</issn><issn>1873-7544</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkt2K1TAUhYsoznH0FSQIemVr0qQ_8ULQUUdhUPAHvAu76a4nZ9KmJunAeQGf25RTGPHK3ATCt9fOXmtn2RNGC0ZZ_eJQTLh4F7TBSWNRUloXjBWUl3eyHWsbnjeVEHezHeW0zkVVlmfZgxAONJ1K8PvZGWtK2lSt2GW_PxntopmMJqAxHq3eO2smJB41ztF5AlOEn24yISZm9m5GH4_EDSTukQS0qKO5QdK7Gca1cJkjXCMx0950Jgk8J5dvvuSslFSmR-Ihkr2ZZ6dhnMGSYI3G8DC7N4AN-Gi7z7Pv7999u_iQX32-_Hjx-irXQoqYC6SATY9sgEp3bcW6emiB91RWmnMGINNYfGg6EEJqYJUuseN900vKNS-Bn2fPTrppkF8LhqhGEzRaCxO6JSgma8l5KxL48gTqZHTwOKjZmxH8UTGq1hTUQf2dglpTUIyplEIqfrx1WboR-9vSzfYEPN0ACBrs4GHSJtxybVWJUsrEvT1xmDy5MejV1q43KZ-oemf-7z-v_pHRdo0c7DUeMRzc4qfkumIqlIqqr-verGtD6yQs6A_-B-S4xHg</recordid><startdate>20070302</startdate><enddate>20070302</enddate><creator>Szasz, B.K</creator><creator>Vizi, E.S</creator><creator>Kiss, J.P</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>20070302</creationdate><title>Nicotinic acetylcholine receptor antagonistic property of the selective dopamine uptake inhibitor, GBR-12909 in rat hippocampal slices</title><author>Szasz, B.K ; Vizi, E.S ; Kiss, J.P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c494t-4e0ae7de1fa5cb851b6f8a3d095c331aa90753f7ba449ca15c2eb3d7d903c32a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Anesthetics, Local - pharmacology</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Dopamine Uptake Inhibitors - pharmacology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>GBR-12909</topic><topic>Hippocampus - drug effects</topic><topic>In Vitro Techniques</topic><topic>Male</topic><topic>monoamine uptake systems</topic><topic>Neurology</topic><topic>Nicotine - metabolism</topic><topic>Nicotine - pharmacology</topic><topic>nicotinic acetylcholine receptors</topic><topic>Nicotinic Antagonists - pharmacology</topic><topic>Piperazines - pharmacology</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>selective dopamine uptake inhibitors</topic><topic>Tetrodotoxin - pharmacology</topic><topic>Tritium - metabolism</topic><topic>Vertebrates: nervous system and sense organs</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Szasz, B.K</creatorcontrib><creatorcontrib>Vizi, E.S</creatorcontrib><creatorcontrib>Kiss, J.P</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>Neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Szasz, B.K</au><au>Vizi, E.S</au><au>Kiss, J.P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nicotinic acetylcholine receptor antagonistic property of the selective dopamine uptake inhibitor, GBR-12909 in rat hippocampal slices</atitle><jtitle>Neuroscience</jtitle><addtitle>Neuroscience</addtitle><date>2007-03-02</date><risdate>2007</risdate><volume>145</volume><issue>1</issue><spage>344</spage><epage>349</epage><pages>344-349</pages><issn>0306-4522</issn><eissn>1873-7544</eissn><coden>NRSCDN</coden><abstract>Abstract Previously we found that inhibitors of noradrenaline (NA) and/or 5-HT reuptake are able to inhibit neuronal nicotinic acetylcholine receptors (nAChRs) in the CNS most probably by a channel blocker-type mechanism. The aim of our study was to clarify whether selective dopamine uptake inhibitors also possess this property, therefore we investigated the effect of GBR-12909 on the nicotine-evoked release of [3 H]NA from rat hippocampal slices. GBR-12909, similar to selective NA and 5-HT uptake blockers, inhibited the nicotine-evoked release with an IC50 of 2.32 μM. The ability of monoamine uptake blockers to inhibit nicotine-evoked [3 H]NA release (IC50 ) and NA reuptake ( Ki ) showed no correlation, indicating that the NA uptake system is not involved in the inhibition of the response to nicotine. Previously we have shown in whole cell patch clamp experiments, that GBR-12909, depending on the stimulation pattern, inhibits Na+ -currents with an IC50 in the 6–35 μM concentration range [Mike A, Karoly R, Vizi ES, Kiss JP (2003) Inhibitory effect of the DA uptake blocker GBR-12909 on sodium channels of hippocampal neurons. Neuroreport 14:1945–1949]. To study whether the inhibition of Na+ -channels is involved in the action of GBR-12909 on the nicotine-evoked [3 H]NA release, we compared the effect of GBR-12909 and the Na+ -channel blocker tetrodotoxin (TTX) on the electrical stimulation- and nicotine-evoked response. TTX prevented the release of [3 H]NA induced by both types of stimulation, whereas GBR-12909 inhibited only the nicotine-induced response, indicating that under our experimental conditions the target of GBR-12909 is not the Na+ -channel. These data indicate that the selective DA uptake inhibitor GBR-12909 is able to inhibit nAChRs, that is, the nAChR antagonistic property of monoamine uptake inhibitors is independent of their selectivity. The fact that monoamine uptake inhibitors with different chemical structure and selectivity are able to inhibit nAChRs may reveal some common properties of nicotinic receptors and monoamine uptake carriers.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>17207584</pmid><doi>10.1016/j.neuroscience.2006.11.032</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0306-4522
ispartof Neuroscience, 2007-03, Vol.145 (1), p.344-349
issn 0306-4522
1873-7544
language eng
recordid cdi_proquest_miscellaneous_19693384
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Anesthetics, Local - pharmacology
Animals
Biological and medical sciences
Dopamine Uptake Inhibitors - pharmacology
Dose-Response Relationship, Drug
Fundamental and applied biological sciences. Psychology
GBR-12909
Hippocampus - drug effects
In Vitro Techniques
Male
monoamine uptake systems
Neurology
Nicotine - metabolism
Nicotine - pharmacology
nicotinic acetylcholine receptors
Nicotinic Antagonists - pharmacology
Piperazines - pharmacology
Rats
Rats, Wistar
selective dopamine uptake inhibitors
Tetrodotoxin - pharmacology
Tritium - metabolism
Vertebrates: nervous system and sense organs
title Nicotinic acetylcholine receptor antagonistic property of the selective dopamine uptake inhibitor, GBR-12909 in rat hippocampal slices
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T13%3A56%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nicotinic%20acetylcholine%20receptor%20antagonistic%20property%20of%20the%20selective%20dopamine%20uptake%20inhibitor,%20GBR-12909%20in%20rat%20hippocampal%20slices&rft.jtitle=Neuroscience&rft.au=Szasz,%20B.K&rft.date=2007-03-02&rft.volume=145&rft.issue=1&rft.spage=344&rft.epage=349&rft.pages=344-349&rft.issn=0306-4522&rft.eissn=1873-7544&rft.coden=NRSCDN&rft_id=info:doi/10.1016/j.neuroscience.2006.11.032&rft_dat=%3Cproquest_cross%3E19693384%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19693384&rft_id=info:pmid/17207584&rft_els_id=S030645220601640X&rfr_iscdi=true